EXAGERADA PRODUCCIÓN DE SUPERÓXIDO POR LOS NEUTRÓFILOS DE PACIENTES CON HEPATITIS ALCOHÓLICA AGUDA: IMPLICANCIA TERAPÉUTICA

BIBLIOGRAFÍA

1. Alcoholic Liver Disease: Pathology and pathogenesis. 2nd Edition. Pauline Hall. 1995.

2. Dávalos M, Rolando N. Hepatitis Alcohólica. Rev Gastroenterol Perú 1998.

3. International Group. Alcoholic Liver Disease: Morphological manifestations. Lancet 1981; 1: 707-771.

4. Mendenhall CL, Anderson S, Garcia-Pont P, Goldberg S, Kieman T, Seef LB, Sorrell M, Tamburro C, Weesner R, Zetterman R, Chedid A, Chen T, Rabin L. Veterans Administration Cooperative Study on Alcoholic Hepatitis. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolona and prednisolone. N Engl J Med 1984; 311:1464-1470.

5. Orrego H, Blake JE, Blendis LM, Medline A. Prognosis of alcoholic cirrhosis in the presence and abscense of alcoholic hepatitis. Gastroenterology 1987; 92: 208-214.

6. Mathurin P, Duchatelle V, Ramond MJ, Degott C, Bedosa P, Erlinger S, Benhamou JP, Chaput JC, Rueff B, Poinard T. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 1996; 110: 1847-1853.

7. Adams David. Leucocyte adhesion molecules and alcoholic liver disease. Alcohol & Alcoholism, 1994; 29(3): 249-260.

8. Lands William. Cellular signals in alcohol-induced liver injury: A review. Alcohol Clin Exp Res 1995;19(4):928-938.

9. Sherman D, Williams R. Liver damage: mechanisms and management. Bri Med Bull 1994; 30(1): 124-138.

10. Williams R, Barry R. Free radical generation by neutrophils: a potential mechanism of cellular injury in acute alcoholic hepatitis. Gut 1987; 28(9): 1157-1161.

11. Bautista A. Chronic alcohol intoxication enhances the expression of CD18 adhesion molecules on rat neutrophils and release of a chemotactic factor by Kupffer cells. Alcohol Clin Exp Res 1995; 19(2): 285-290.

12. Adams D, Burra P, Hubscher S, Elias E, Newman W. Endothelial activation and circulating vascular adhesion molecules in alcoholic liver disease. Hepatology 1994; 19: 588-594.

13. Sheron N, Bird G, Koskinas J, Portmann B, Ceska M, Lindley I, Williams R. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 1993; 18: 41-46.

14. Shiratori Y, Takada H, Hikiba R, Nakata R, Okano K, Komatsu Y, Niwa Y, Matsumura M, Shiian S, Omata M. Production of chemotactic factor, interleukine-8 from hepatocytes exposed to ethanol. Hepatology 1993; 18:1477-1482.

15. Hill DB, Marsano LS, McClain CJ. Increased plasma IL-8 concentration in alcoholic hepatitis. Hepatology 1994; 18: 576-580.

16. Burra P, Hubscher SJ, Shaw J, Elias E, Adams DH. Is the intracellular adhesion molecule-1/leukocyte function associated antigen 1 pathway of leukocyte adhesion involved in the tissue damage of alcoholic hepatitis? Gut 1992; 33: 268-271.

17. Aderem Alan. How cytokines signal messages within cells. J Infect Dis 1993; 167(Suppl 1): S2-7.

18. Newberger P, Chovanec M, Cohen H. Activity and activation of the granulocyte superoxide-generating system. Blood 1980; 55(1): 85-92.

19. Epstein F. Tissue destruction by Neutrophils. N Engl J Med 1989; 320(6):365-376.

20. Fantone JC and Ward PA. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Amer J Pathol 1982; 107: 397-414.

21. Johnston RB, Keele BB, Misra HP, Lehmeyer JE, Webb LS, Baehner RL, Rajagopalan KV. The role of superoxide anion generation in phagocytic bactericidal activity. J Clin Invest 1975; 55: 1357-1372.

22. Boyum A. Isolation of mononuclear cells and granulocytes from human peripheral blood. Scan J Clin Lab Invest 1968; 21 (Spp.97); 77-89.

23. Beswick PM, Brannen Pc, Hurles SS. The effects of smoking and zinc on the oxidative reactions of human neutrophils. J Clin Lab Inmunol 1986; 21:71-75.

24. Pick E, Mizel D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme inmunoassay reader. J Inmunol Methods 1981; 46:211-226.

25. Lieber CS. Alcoholic liver disease. Sem Liv Dis 1993;13:105-108.

26. Dufour MC, Stinson FS, Caces MF et al. Trends in cirrhosis morbidity and mortality: United States 1979-1988. Sem Liv Dis 1993;13:109-125.

27. Treatments in Hepatology. Vicente Arroyo, Jaime Bosch, Juan Rodés. 1995. Editorial Masson SA, Barcelona España. Section 7, pp 265-314.

28. Spitzer JA, Zhang P, Mayer AMS. Funtional characterization of peripheral circulating and liver recruited neutophils in endotoxic rats. J. Leukoc Biol 1994; 56:166 73.

29. Zhang P, Spitzer JA. Acute ethanol administration modulates leukocite actin polymerizaion en endotoxic rats. Alcohol Clin Exp Res 1997; 21:779-783.

30. Hallet MB, Lloyds D. Neutrophil priming: the cellular signals that say 'amber' but not 'green'. Immunology Today 1995;16:264-268.

31. Mezey E. Treatment of alcoholic liver disease. Sem Liv Dis 1993; 13(2): 210-216.

32. Maddrey WC, Boinott JK, Bedine MS, Weber FL, Mezey E, White RI. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75: 193-199.

33. Theodossi A, Eddleston WF, Williams R. Controlled trial of methylprednisolone in severe alcoholic hepatitis. Gut 1982; 23: 75-79.

34. Carithers RL, Herlong F, Diehl AM, Shaw EW, Combes B, Fallon HJ, Maddrey WC. Methylprednisolone therapy in patients with severe alcoholic liver hepatitis. A randomized multicenter trial. Ann Intern Med 1989; 110: 685-690.

35. Hofer T, MacMahon L. Corticosteroids and alcoholic hepatitis. Hepatology 1991; 13(1): 199-201.

36. Imperiale TF, McCullough AJ. Do corticosteroids reduce mortality from alcoholic hepatitis- A meta-analysis of the randomized trials. Ann intern Med. 1990; 113(4): 299-307.

37. Christensen E, Gluud C. Glucocorticoids are ineffective in alcoholic hepatitis: A meta-analysis adjusting confounding variables. Gut 1995; 37: 113-118.

38. Ramond MJ, Poinard T, Rueff B, Mathurin P, Theodore C, Chaput J, Benhamou JP. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992; 326; 507-512.

39. Goodman & Gilman. The Pharmacological Basis of Therapeutic. 9th Ed. 1996.

40. Fukushima K, Ando M, Ito K, Suga M, Araki S. Stimulus- and cumulative dose-dependent inhibition of O2- production by polymorphonuclear leukocytes of patients receiving corticosteroids. J Clin Lab Inmunol 1990; 33: 117-123.

41. Adams DH, Wang LF, Burnett D, Stockley RA, Nauberger JM. Neutrophil activation -an important cause of tissue damage during liver allograft rejection? Transplantation 1990; 50(1): 86-91.

42. Norris DA, Capin L, Weston WL. The effect of epicutaneous glucocorticosteroids on human monocyte and neutrophil migration in vivo. J Invest Dermatol. 1982; 78(5): 386-390.

43. Lieber CS. Alcohol and the liver: 1994 update. Gastroenterology 1994; 106: 1085-1105.

44. Nordmann R. Alcohol and Antioxidant Systems. Alcohol & Alcohol 1994; 29: 513-522.

Regresar al Artículo

Regresar